<!DOCTYPE html>
<html class="">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
      <title>Pulmonary embolism - Epidemiology | BMJ Best Practice</title>
      <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
      <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
      <meta name="description" content="Pulmonary embolism (PE) is a life-threatening condition resulting from dislodged thrombi occluding the pulmonary vasculature; right heart failure and cardiac arrest may ensue if not aggressively treated. Symptoms include chest pain, dyspnoea, and a sense of apprehension. Haemoptysis and syncope a...">
      <!-- Optimize Page Hiding Snippet --> 
      <!-- <style>.async-hide
         { opacity: 0 !important}
      </style>
      <script async="" src="../js/adrum-ext.0086dbec5e8a6e717bf36d3a06b62042.js"></script><script src="../js/414393182248444" async=""></script><script async="" src="../js/fbevents.js"></script><script type="text/javascript" async="" src="../js/analytics.js"></script><script async="" src="../js/get-loader.js"></script><script type="text/javascript" async="" src="../js/insight.min.js"></script><script type="text/javascript" async="" src="../js/js"></script><script type="text/javascript" async="" src="../js/uwt.js"></script><script type="text/javascript" async="" src="../js/4896.js"></script><script type="text/javascript" async="" src="../js/analytics.js"></script><script async="" src="../js/gtm.js"></script><script>(function(a,s,y,n,c,h,i,d,e){s.className+=' '+y;h.start=1*new Date; h.end=i=function()
         {s.className=s.className.replace(RegExp(' ?'+y),'')}
         ; (a[n]=a[n]||[]).hide=h;setTimeout(function()
         
         {i();h.end=null}
         ,c);h.timeout=c;})(window,document.documentElement,'async-hide','dataLayer',3000,
         
         {'GTM-K3TZ3JV':true}
         );
      </script> -->
      <!-- end Optimize Page Hiding Snippet -->
      <!-- Google Tag Manager -->
      <script>
         /*<![CDATA[*/
         
          
         window.dataLayer = window.dataLayer || [];
         window.dataLayer.push({
                    'icsId': null,
                    'pi_icsId': "id82087",
                    'pi_icsName': "BMJ Group (Online access from BMA House)",
                    'access_rights': true,
                    'ics_groupings': [{"name":"Country Grouping"}],
                    'ics_countryName': "GB and ROW",
                    'siteLanguage': "en-gb",
                    'contentLanguage': "en-gb"
                 });
         		  
         /*]]>*/
            
      </script>
      <script>
         (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
         new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
         j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
         'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
         })(window,document,'script','dataLayer', 'GTM-K3TZ3JV');
      </script>
      <!-- End Google Tag Manager -->
      <!-- /* if user in China */ -->
      <link rel="stylesheet" type="text/css" media="screen" href="../css/material.css">
      <link rel="stylesheet" type="text/css" media="screen" href="../css/styles.css">
      <link rel="stylesheet" type="text/css" media="screen" href="../css/external.css">
      <link rel="shortcut icon" href="https://resources.bmj.com/repository/images/favicon.ico">
      <link rel="canonical" href="https://bestpractice.bmj.com/topics/en-gb/116/epidemiology">
      <link rel="alternate" hreflang="uk-ua" href="https://bestpractice.bmj.com/topics/uk-ua/116/epidemiology">
      <link rel="alternate" hreflang="en-ie" href="https://bestpractice.bmj.com/topics/en-gb/116/epidemiology">
      <link rel="alternate" hreflang="az-az" href="https://bestpractice.bmj.com/topics/az-az/116/epidemiology">
      <link rel="alternate" hreflang="en-us" href="https://bestpractice.bmj.com/topics/en-us/116/epidemiology">
      <link rel="alternate" hreflang="ru" href="https://bestpractice.bmj.com/topics/ru-ru/116/epidemiology">
      <link rel="alternate" hreflang="pt" href="https://bestpractice.bmj.com/topics/pt-br/116/epidemiology">
      <link rel="alternate" hreflang="ka-ge" href="https://bestpractice.bmj.com/topics/ka-ge/116/epidemiology">
      <link rel="alternate" hreflang="pt-br" href="https://bestpractice.bmj.com/topics/pt-br/116/epidemiology">
      <link rel="alternate" hreflang="en" href="https://bestpractice.bmj.com/topics/en-gb/116/epidemiology">
      <link rel="alternate" hreflang="es-es" href="https://bestpractice.bmj.com/topics/es-es/116/epidemiology">
      <link rel="alternate" hreflang="zh-cn" href="https://bestpractice.bmj.com/topics/zh-cn/116/epidemiology">
      <link rel="alternate" hreflang="es" href="https://bestpractice.bmj.com/topics/es-es/116/epidemiology">
      <link rel="alternate" hreflang="zh" href="https://bestpractice.bmj.com/topics/zh-cn/116/epidemiology">
      <link rel="alternate" hreflang="x-default" href="https://bestpractice.bmj.com/topics/en-gb/116/epidemiology">
      <link rel="alternate" hreflang="ru-ru" href="https://bestpractice.bmj.com/topics/ru-ru/116/epidemiology">
      <link rel="alternate" hreflang="vi" href="https://bestpractice.bmj.com/topics/vi-vn/116/epidemiology">
      <link rel="alternate" hreflang="uk" href="https://bestpractice.bmj.com/topics/uk-ua/116/epidemiology">
      <link rel="alternate" hreflang="ka" href="https://bestpractice.bmj.com/topics/ka-ge/116/epidemiology">
      <link rel="alternate" hreflang="az" href="https://bestpractice.bmj.com/topics/az-az/116/epidemiology">
      <link rel="alternate" hreflang="vi-vn" href="https://bestpractice.bmj.com/topics/vi-vn/116/epidemiology">
      <link rel="alternate" hreflang="en-gb" href="https://bestpractice.bmj.com/topics/en-gb/116/epidemiology">
      <!--[if lte IE 9]>
      <link rel="stylesheet" type="text/css" media="screen" href="/gzip_1791a8687c5480ce19e791d0825e7a6b/css/lte-ie-9.css" >
      <![endif]-->
      <script>
         /*<![CDATA[*/
           var appdynamics_app_key="AD-AAB-AAF-RGR";
         /*]]>*/
           	window["adrum-app-key"] = appdynamics_app_key;
           	window['adrum-start-time'] = new Date().getTime();
           
      </script>
      <script type="text/javascript" src="../js/appdynamics.js"></script>
      <script type="application/ld+json">
         [
         
         { "@context": "http://schema.org", "@type": "MedicalCondition" }
         ,{
         "isAccessibleForFree": "False",
         "hasPart":
         
         { "@type": "WebPageElement", "isAccessibleForFree": "False", "cssSelector" : ".gpw" }
         }]
      </script>
      <style></style>
   </head>
   <body class="gpw">
      <div role="dialog" aria-live="polite" aria-label="cookieconsent" aria-describedby="cookieconsent:desc" class="cc-window cc-banner cc-type-info cc-theme-classic cc-bottom cc-color-override--38786966 cc-invisible" style="display: none;">
         <!--googleoff: all--><span id="cookieconsent:desc" class="cc-message">We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our 
         <a aria-label="learn more about cookies" role="button" tabindex="0" class="cc-link" href="https://www.bmj.com/company/your-privacy/cookies-policy/" target="_blank">cookies policy</a></span>
         <div class="cc-compliance"><a aria-label="dismiss cookie message" role="button" tabindex="0" class="cc-btn cc-dismiss">OK!</a></div>
         <!--googleon: all-->
      </div>
      <!-- Google Tag Manager (noscript) -->
      <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-K3TZ3JV" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
      <!-- End Google Tag Manager (noscript) -->
      <!-- /* if user in China */ -->
      <header id="header" role="banner">
         <a class="sr-only" href="https://bestpractice.bmj.com/topics/en-gb/116/epidemiology#sr-content">Skip to main content</a>
         <div class="bg-info text-white">
         </div>
         <nav id="globalNav" class="logo-img-mob navbar navbar-toggleable-md">
            <div class="container">
               <a href="https://bestpractice.bmj.com/" class="mobLogo"><span class="remove"><abbr>BMJ</abbr> Best Practice</span></a>
               <button class="navbar-toggler navbar-toggler-right" type="button" data-toggle="collapse" data-target="#navbarNav" aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation">
               <span class="material-icons"></span>
               </button>
               <div id="navbarNav" class="collapse navbar-collapse">
                  <ul id="globalNav-ul" class="navbar-nav" role="menubar">
                     <li id="globalNav-access" class="nav-item" role="presentation">
                        <span class="nav-link"> 
                        Access provided by: 
                        BMJ Group (Online access from BMA House)
                        </span>
                     </li>
                     <li id="globalNav-help" class="nav-item dropdown" role="menuitem">
                        <a href="https://bestpractice.bmj.com/topics/en-gb/116/epidemiology#" id="navbarDropdownMenuLink02" class="nav-link dropdown-toggle" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false"> 
                        Help <span class="states">
                        <span class="material-icons"></span>
                        <span class="material-icons"></span>
                        </span>
                        </a>
                        <div id="globalNav-help-options" class="dropdown-menu dropdown-menu-right" aria-labelledby="navbarDropdownMenuLink02">
                           <span class="material-icons"></span>
                           <ul role="menu">
                              <li class="dropdown-item"><a href="https://bestpractice.bmj.com/info/getting-started/" target="_blank">Getting started</a></li>
                              <li class="dropdown-item"><a href="https://bestpractice.bmj.com/info/faq/" target="_blank">FAQs</a></li>
                              <li class="dropdown-item"><a href="https://bestpractice.bmj.com/info/benefits-features/earn-cme-points/" target="_blank">About CME/CPD</a></li>
                              <li class="dropdown-item"><a href="https://bestpractice.bmj.com/info/contact-us/" target="_blank">Contact us</a></li>
                           </ul>
                        </div>
                     </li>
                     <li id="globalNav-register" class="nav-item">
                        <a href="https://bestpractice.bmj.com/registration" class="nav-link">Create account</a>
                     </li>
                     <li id="globalNav-login" class="nav-item">
                        <a href="https://bestpractice.bmj.com/login" class="nav-link">Log in</a>
                     </li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/recent-updates"><span class="icon icon-bp-icons-recent-updates"></span><span>Recent updates</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/specialties"><span class="icon icon-bp-icons-specialties"></span><span>Specialties</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/calculators"><span class="icon icon-bp-icons-calculators"></span><span>Calculators</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/patient-leaflets"><span class="icon icon-bp-icons-patient-leaflets"></span><span>Patient leaflets</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/procedural-videos"><span class="icon icon-bp-icons-procedural-videos"></span><span>Procedural videos</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/evidence"><span class="icon icon-bp-icons-evidence"></span><span>Evidence</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/drugs"><span class="icon icon-bp-icons-drugs"></span><span>Drugs</span></a></li>
                  </ul>
               </div>
            </div>
         </nav>
         <div id="mainSearch" class="container">
            <div class="row">
               <div class="col-lg-7">
                  <div class="logo-img"><a href="https://bestpractice.bmj.com/"><span class="remove"><abbr title="British Medical Journal">BMJ</abbr> Best Practice</span></a></div>
               </div>
               <div class="col-lg-5">
                  <style type="text/css">
                     #searchBoxWrap .tt-open:before {content: "Recently viewed topics:"; }
                     #searchBoxWrap .tt-label-override:before,
                     #searchBoxWrap .tt-suggested:before {content: "Suggested topics:" !important; }
                  </style>
                  <form id="searchBoxForm" action="https://bestpractice.bmj.com/search" role="search" novalidate="novalidate">
                     <div class="input-group">
                        <div id="searchBoxWrap">
                           <label for="q" class="sr-only">Search</label>
                           <span class="twitter-typeahead" style="position: relative; display: inline-block;">
                              <input id="q" type="text" name="q" placeholder="Search conditions, symptoms..." value="" class="tt-input" autocomplete="off" spellcheck="false" dir="auto" style="position: relative; vertical-align: top;">
                              <pre aria-hidden="true" style="position: absolute; visibility: hidden; white-space: pre; font-family: sans-serif; font-size: 16px; font-style: normal; font-variant: normal; font-weight: 400; word-spacing: 0px; letter-spacing: 0px; text-indent: 0px; text-rendering: auto; text-transform: none;"></pre>
                              <div class="tt-menu" style="position: absolute; top: 100%; left: 0px; z-index: 100; display: none;">
                                 <div class="tt-dataset tt-dataset-0"></div>
                              </div>
                           </span>
                           <button id="mainSearchBtn" type="submit"><span class="material-icons"></span></button>
                        </div>
                     </div>
                  </form>
                  <script>
                     /*<![CDATA[*/
                     
                            // These are required in completion, see BP-232 -->
                            var searchDefaultLanguageCode = "en-gb";
                            var regionName = "GB and ROW";
                            var regionAvailableLanguagesCodes = [{"id":"1","code":"en-gb","displayName":"English"},{"id":"3","code":"pt-br","displayName":"Portugu\u00EAs"},{"id":"5","code":"es-es","displayName":"Espa\u00F1ol"},{"id":"7","code":"ru-ru","displayName":"\u0420\u0443\u0441\u0441\u043A\u0438\u0439"}];
                            var availableLanguages = [];
                     
                            for (i = 0; i < regionAvailableLanguagesCodes.length; i++) {
                                availableLanguages.push(regionAvailableLanguagesCodes[i].code);
                            }
                     /*]]>*/
                  </script>
               </div>
            </div>
         </div>
         <nav id="mainNav" class="navbar navbar-toggleable-md" role="navigation">
            <div class="container">
               <div id="mainNavbarNav">
                  <ul class="navbar-nav" role="menubar">
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/recent-updates"><span class="icon icon-bp-icons-recent-updates"></span><span>Recent updates</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/specialties"><span class="icon icon-bp-icons-specialties"></span><span>Specialties</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/calculators"><span class="icon icon-bp-icons-calculators"></span><span>Calculators</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/patient-leaflets"><span class="icon icon-bp-icons-patient-leaflets"></span><span>Patient leaflets</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/procedural-videos"><span class="icon icon-bp-icons-procedural-videos"></span><span>Procedural videos</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/evidence"><span class="icon icon-bp-icons-evidence"></span><span>Evidence</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/drugs"><span class="icon icon-bp-icons-drugs"></span><span>Drugs</span></a></li>
                  </ul>
               </div>
            </div>
         </nav>
      </header>
      <main id="tmp" class="container tmp tmp-basic main-container" role="main">
         <script type="text/javascript">
            /*<![CDATA[*/ 
            var topicId = 116; 
            var langCode="en-gb"; 
            /*]]>*/
         </script>
         <div id="topicNav" class="container">
            <div class="lang">
               <ul role="menu">
                  <li><a href="https://bestpractice.bmj.com/topics/en-gb/116" class="active">English</a></li>
                  <li><a href="https://bestpractice.bmj.com/topics/pt-br/116">Português</a></li>
                  <li><a href="https://bestpractice.bmj.com/topics/es-es/116">Español</a></li>
                  <li><a href="https://bestpractice.bmj.com/topics/ru-ru/116">Русский</a></li>
               </ul>
            </div>
            <div id="topicMenuTopBg" style="height: 110px;"></div>
            <div id="topicMenuTopWrap" style="height: 110px;">
               <div id="topicMenuTop" style="height: 110px;">
                  <h1>Pulmonary embolism</h1>
                  <div class="pdf-links-nav">
                     <div class="pdf">
                        <a href="https://bestpractice.bmj.com/topics/en-gb/116/pdf/116.pdf" target="_blank">
                        <span class="icon icon-bp-icons-pdf-extra-small-on-white"></span> <span>View PDF</span>
                        </a>
                     </div>
                  </div>
                  <div id="mobileMenu" class="mUp">
                     <a href="https://bestpractice.bmj.com/topics/en-gb/116/epidemiology#" role="button">
                     <span><span class="material-icons"></span> Menu</span>
                     <span><span class="material-icons"></span> Close</span>
                     </a>
                  </div>
                  <ul id="menuLinks" role="menu">
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/116/epidemiology#smenu-0" aria-owns="menu-0">Overview <span class="material-icons"></span><span class="material-icons"></span></a></li>
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/116/epidemiology#smenu-1" aria-owns="menu-1">Theory <span class="material-icons"></span><span class="material-icons"></span></a></li>
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/116/epidemiology#smenu-2" aria-owns="menu-2">Diagnosis <span class="material-icons"></span><span class="material-icons"></span></a></li>
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/116/epidemiology#smenu-3" aria-owns="menu-3">Management <span class="material-icons"></span><span class="material-icons"></span></a></li>
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/116/epidemiology#smenu-4" aria-owns="menu-4">Follow up <span class="material-icons"></span><span class="material-icons"></span></a></li>
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/116/epidemiology#smenu-5" aria-owns="menu-5">Resources <span class="material-icons"></span><span class="material-icons"></span></a></li>
                  </ul>
               </div>
            </div>
            <div id="topicMenuBottomWrap" style="height: 176px;">
				<nav id="topicMenuBottom" class="mUp" role="navigation" style="height: 176px;">
					<ul id="menus" role="menubar">
					   <li>
						  <a href="https://bestpractice.bmj.com/topics/en-gb/116/criteria#" class="parent"><span>Overview</span><span class="material-icons"></span><span class="material-icons"></span></a>
						  <ul role="menu" id="menu-0">
							 <li><a href="116_overview_summary.html" id="Summary">Summary</a></li>
						  </ul>
					   </li>
					   <li>
						  <a href="https://bestpractice.bmj.com/topics/en-gb/116/criteria#" class="parent"><span>Theory</span><span class="material-icons"></span><span class="material-icons"></span></a>
						  <ul role="menu" id="menu-1">
							 <li><a href="116_theory_summary.html" id="Epidemiology" class="active">Epidemiology</a></li>
							 <li><a href="116_theory_aetiology.html" id="Aetiology">Aetiology</a></li>
							 <li><a href="116_theory_case_history.html" id="Case history">Case history</a></li>
						  </ul>
					   </li>
					   <li>
						  <a href="https://bestpractice.bmj.com/topics/en-gb/116/criteria#" class="parent"><span>Diagnosis</span><span class="material-icons"></span><span class="material-icons"></span></a>
						  <ul role="menu" id="menu-2">
							 <li><a href="116_diagnosis_recommendations.html" id="Approach">Recommendations</a></li>
							 <li><a href="116_diagnosis_history-exam.html" id="History and exam">History and exam</a></li>
							 <li><a href="116_diagnosis_investigations.html" id="Investigations">Investigations</a></li>
							 <li><a href="116_diagnosis_differentials.html" id="Differentials">Differentials</a></li>
							 <li><a href="116_diagnosis_criteria.html" id="Criteria">Criteria</a></li>
						  </ul>
					   </li>
					   <li>
						  <a href="https://bestpractice.bmj.com/topics/en-gb/116/criteria#" class="parent"><span>Management</span><span class="material-icons"></span><span class="material-icons"></span></a>
						  <ul role="menu" id="menu-3">
							 <li><a href="116_management_recommendations.html" id="Approach">Recommendations</a></li>
							 <li><a href="116_management_treatment_algorithm.html" id="Treatment algorithm">Treatment algorithm</a></li>
							 <li><a href="116_management_emerging.html" id="Emerging">Emerging</a></li>
							 <li><a href="116_management_prevention.html" id="Prevention">Prevention</a></li>
							 <li><a href="116_management_patient_discussions.html" id="Patient discussions">Patient discussions</a></li>
						  </ul>
					   </li>
					   <li>
						  <a href="https://bestpractice.bmj.com/topics/en-gb/116/criteria#" class="parent"><span>Follow up</span><span class="material-icons"></span><span class="material-icons"></span></a>
						  <ul role="menu" id="menu-4">
							 <li><a href="116_follow_up_monitoring.html" id="Monitoring">Monitoring</a></li>
							 <li><a href="116_follow_up_complications.html" id="Complications">Complications</a></li>
							 <li><a href="116_follow_up_prognosis.html" id="Prognosis">Prognosis</a></li>
						  </ul>
					   </li>
					   <li>
						  <a href="https://bestpractice.bmj.com/topics/en-gb/116/criteria#" class="parent"><span>Resources</span><span class="material-icons"></span><span class="material-icons"></span></a>
						  <ul role="menu" id="menu-5">
							 <li><a href="116_resources_guidelines.html" id="Guidelines">Guidelines</a></li>
							 <li><a href="116_resources_images_videos.html" id="Images and videos">Images and videos</a></li>
							 <li><a href="116_resources_references.html" id="References">References</a></li>
							 <li><a href="116_resources_patient_leaflets.html" id="Patient leaflets">Patient leaflets</a></li>
							 <li><a href="116_resources_evidence.html" id="Evidence">Evidence</a></li>
						  </ul>
					   </li>
					   <li class="mpdf"><a href="https://bestpractice.bmj.com/topics/en-gb/116/pdf/116.pdf" target="_blank"><span class="icon icon-bp-icons-pdf-extra-small-on-white"></span> <span>View PDF</span></a></li>
					</ul>
				 </nav>
            </div>
         </div>
         <h2 id="sr-content">Epidemiology</h2>
         <div class="card">
            <div class="card-block">
               <section>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     In the UK, 47,594 cases of PE were reported in the 1-year period between 2013 and 2014.
                     <span class="web-link-wrap"> 
                     <a rel="external" target="_blank" href="http://www.hscic.gov.uk/catalogue/PUB16719">
                     Hospital episode statistics, admitted patient care: England 2013-2014
                     <span class="icon icon-bp-icons-outbound-link"></span>
                     </a>
                     </span>
                     Data from the Swedish National Patient Registry indicate that, in 2005, there were 5793 patients of all ages diagnosed with acute PE (national incidence 0.6/1000/year).
                     <span class="reference"> 
                     <a href="#referencePop7" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[7]</a> 
                     <span class="citationText" aria-hidden="true">Andersson T, Söderberg S. Incidence of acute pulmonary embolism, related comorbidities and survival; analysis of a Swedish national cohort. BMC Cardiovasc Disord. 2017 Jun 14;17(1):155.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-017-0587-1
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/28615009?tool=bestpractice.com
                     </span>
                     </span>
                     Of 317,000 deaths related to venous thromboembolism (VTE) in 6 European Union countries (population 454 million) in 2004, 34% were attributable to sudden fatal PE, 59% from PE-related deaths following undiagnosed VTE, and 7% from correctly diagnosed PE.
                     <span class="reference"> 
                     <a href="#referencePop8" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[8]</a> 
                     <span class="citationText" aria-hidden="true">Cohen AT, Agnelli G, Anderson FA, et al; VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe: the number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007 Oct;98(4):756-64.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/17938798?tool=bestpractice.com
                     </span>
                     </span>
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     Between 2007 and 2009, PE resulted in 277,549 adult (≥18 years) hospitalisations in the US.
                     <span class="reference"> 
                     <a href="#referencePop9" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[9]</a> 
                     <span class="citationText" aria-hidden="true">Centers for Disease Control and Prevention (CDC). Venous thromboembolism in adult hospitalizations - United States, 2007-2009. MMWR Morb Mortal Wkly Rep. 2012 Jun 8;61(22):401-4.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6122a1.htm
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/22672974?tool=bestpractice.com
                     </span>
                     </span>
                     Of these patients, an average of 19,297 died each year. The annual rate of adult hospitalisations with a discharge diagnosis of PE during 2007 to 2009 was 121 per 100,000 population.
                     <span class="reference"> 
                     <a href="#referencePop9" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[9]</a> 
                     <span class="citationText" aria-hidden="true">Centers for Disease Control and Prevention (CDC). Venous thromboembolism in adult hospitalizations - United States, 2007-2009. MMWR Morb Mortal Wkly Rep. 2012 Jun 8;61(22):401-4.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6122a1.htm
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/22672974?tool=bestpractice.com
                     </span>
                     </span>
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     From 1993 to 2012, US National Inpatient Sample recorded an increase in PE admissions from 23 per 100,000 to 65 per 100,000.
                     <span class="reference"> 
                     <a href="#referencePop10" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[10]</a> 
                     <span class="citationText" aria-hidden="true">Smith SB, Geske JB, Kathuria P, et al. Analysis of national trends in admissions for pulmonary embolism. Chest. 2016 Jul;150(1):35-45.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/26905364?tool=bestpractice.com
                     </span>
                     </span>
                     &nbsp;The rate of both massive PE and mortality increased (1.5 to 2.8 per 100,000, and 1.6 to 2.1 per 100,000, respectively), but not commensurate with the increase in admissions.
                     <span class="reference"> 
                     <a href="#referencePop10" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[10]</a> 
                     <span class="citationText" aria-hidden="true">Smith SB, Geske JB, Kathuria P, et al. Analysis of national trends in admissions for pulmonary embolism. Chest. 2016 Jul;150(1):35-45.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/26905364?tool=bestpractice.com
                     </span>
                     </span>
                     &nbsp;The proportion of male patients admitted with PE increased from 44.9% in 1993 to 47.3% in 2012. The majority of patients were white (62.1% in 1993, 70.2% in 2012); however, the proportion of black patients admitted increased significantly (from 8.0% to 15.9%). 
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     Among US adults greater than 65 years of age, the adjusted PE hospitalisation rate increased from 129/100,000 person-years in 1999 to 302/100,000 person-years in 2010.
                     <span class="reference"> 
                     <a href="#referencePop11" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[11]</a> 
                     <span class="citationText" aria-hidden="true">Minges KE, Bikdeli B, Wang Y, et al. National trends in pulmonary embolism hospitalization rates and outcomes for adults aged ≥65 years in the United States (1999 to 2010). Am J Cardiol. 2015 Nov 1;116(9):1436-42.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841688/
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/26409636?tool=bestpractice.com
                     </span>
                     </span>
                  </p>
               </section>
            </div>
         </div>

<!-- NEW RF FROM LIVE -->
<h3 id="riskFactors">Risk factors</h3>
<div id="rfs" class="histExam">

   <div class="card mt-4">
       <div class="card-block">
           <div class="container strong">

               <div class="row rowHead">
                   <h3 id="rfs-strong" class="col-md-12">
                          <a href="#">
                             <span>strong</span>
                             <span class="hidden-sm-down">
                                <span class="msg">VIEW ALL</span>
                                <span class="material-icons" role="button"><span>&#xE313;</span><span>&#xE316;</span></span>
                             </span>
                          </a>
                       </h3>
               </div>

               <!-- this is a list of risk factors -->

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-7300e39d-9c9c-4186-853c-9bf8ae434a1a">
                       <h3>increasing age</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-7300e39d-9c9c-4186-853c-9bf8ae434a1a" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           The incidence and direct mortality from PE increases with age.

                           <span class="reference"> 
              <a href="#referencePop17" data-trigger="click focus" data-toggle="popover" class="referencePop">[17]</a> 
              <span class="citationText" aria-hidden="true">Stein PD, Huang HI, Afzal A, et al. Incidence of acute pulmonary embolism in a general hospital: relation to age, sex, and race. Chest. 1999 Oct;116(4):909-13.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/10531152?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Age-specific mortality rates double for every 10 years starting at age 25.

                           <span class="reference"> 
              <a href="#referencePop18" data-trigger="click focus" data-toggle="popover" class="referencePop">[18]</a> 
              <span class="citationText" aria-hidden="true">Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Arch Intern Med. 2003 Jul 28;163(14):1711-7.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/215882
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/12885687?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-a1e1040b-d8f5-40d3-a2e8-16e671f74e49">
                       <h3>diagnosis of deep vein thrombosis (DVT)</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-a1e1040b-d8f5-40d3-a2e8-16e671f74e49" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Present in 45% to 50% of patients with a diagnosed PE.

                           <span class="reference"> 
              <a href="#referencePop19" data-trigger="click focus" data-toggle="popover" class="referencePop">[19]</a> 
              <span class="citationText" aria-hidden="true">Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999 Apr 24;353(9162):1386-9.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/10227218?tool=bestpractice.com
                 </span>

                           </span>

                           <span class="reference"> 
              <a href="#referencePop20" data-trigger="click focus" data-toggle="popover" class="referencePop">[20]</a> 
              <span class="citationText" aria-hidden="true">Lee JS, Moon T, Kim TH, et al. Deep vein thrombosis in patients with pulmonary embolism: prevalance, clinical significance and outcome. Vasc Specialist Int. 2016 Dec;32(4):166-74.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 http://www.vsijournal.org/journal/view.html?volume=32&amp;number=4&amp;spage=166&amp;year=2016
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/28042556?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-91314e6c-4a08-4652-878a-47927b28fc99">
                       <h3>surgery within the last 2 months</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-91314e6c-4a08-4652-878a-47927b28fc99" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Present in 29% with confirmed PE.

                           <span class="reference"> 
              <a href="#referencePop19" data-trigger="click focus" data-toggle="popover" class="referencePop">[19]</a> 
              <span class="citationText" aria-hidden="true">Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999 Apr 24;353(9162):1386-9.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/10227218?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-8f9c829d-7f9c-4e88-bd95-d350b1b5759c">
                       <h3>bed rest &gt;5 days</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-8f9c829d-7f9c-4e88-bd95-d350b1b5759c" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Present in 28% with confirmed PE.

                           <span class="reference"> 
              <a href="#referencePop19" data-trigger="click focus" data-toggle="popover" class="referencePop">[19]</a> 
              <span class="citationText" aria-hidden="true">Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999 Apr 24;353(9162):1386-9.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/10227218?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-67ae6646-2190-4ca1-b332-244696bfe338">
                       <h3>previous venous thromboembolic event</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-67ae6646-2190-4ca1-b332-244696bfe338" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Present in 25% with confirmed PE.

                           <span class="reference"> 
              <a href="#referencePop19" data-trigger="click focus" data-toggle="popover" class="referencePop">[19]</a> 
              <span class="citationText" aria-hidden="true">Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999 Apr 24;353(9162):1386-9.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/10227218?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-9850f36d-c11b-415b-bfbd-42d504c50ffb">
                       <h3>family history of venous thromboembolism (VTE)</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-9850f36d-c11b-415b-bfbd-42d504c50ffb" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           A family history of VTE is associated with a significantly increased rate of VTE among first-degree relatives.

                           <span class="reference"> 
              <a href="#referencePop21" data-trigger="click focus" data-toggle="popover" class="referencePop">[21]</a> 
              <span class="citationText" aria-hidden="true">Sindet-Pedersen C, Bruun Oestergaard L, Gundlund A, et al. Familial clustering of venous thromboembolism - a Danish nationwide cohort study. PLoS One. 2016 Dec 29;11(12):e0169055.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0169055
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/28033406?tool=bestpractice.com
                 </span>

                           </span>

                           The risk is increased more than 20-fold in patients with at least two affected siblings, making this one of the strongest risk factors identified for VTE.

                           <span class="reference"> 
              <a href="#referencePop22" data-trigger="click focus" data-toggle="popover" class="referencePop">[22]</a> 
              <span class="citationText" aria-hidden="true">Zöller B, Li X, Sundquist J, et al. Age- and gender-specific familial risks for venous thromboembolism: a nationwide epidemiological study based on hospitalizations in Sweden. Circulation. 2011 Aug 30;124(9):1012-20.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/21824919?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-a2399081-d2cf-4533-9d8e-4413dbccd656">
                       <h3>active malignancy</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-a2399081-d2cf-4533-9d8e-4413dbccd656" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Present in 22% with confirmed PE.

                           <span class="reference"> 
              <a href="#referencePop19" data-trigger="click focus" data-toggle="popover" class="referencePop">[19]</a> 
              <span class="citationText" aria-hidden="true">Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999 Apr 24;353(9162):1386-9.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/10227218?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Ovarian, uterine, prostate, and brain cancers are most commonly associated with death due to PE.

                           <span class="reference"> 
              <a href="#referencePop18" data-trigger="click focus" data-toggle="popover" class="referencePop">[18]</a> 
              <span class="citationText" aria-hidden="true">Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Arch Intern Med. 2003 Jul 28;163(14):1711-7.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/215882
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/12885687?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-868872c0-8500-4d8e-b688-5efded8f3273">
                       <h3>recent trauma or fracture</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-868872c0-8500-4d8e-b688-5efded8f3273" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Present in 11% with confirmed PE.

                           <span class="reference"> 
              <a href="#referencePop19" data-trigger="click focus" data-toggle="popover" class="referencePop">[19]</a> 
              <span class="citationText" aria-hidden="true">Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999 Apr 24;353(9162):1386-9.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/10227218?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-af54cebf-3557-44e7-bf54-04b05d01055b">
                       <h3>pregnancy/postnatal period</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-af54cebf-3557-44e7-bf54-04b05d01055b" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           There is a more than 4-fold increased risk of thrombosis throughout gestation, and this risk may increase during the postnatal period.

                           <span class="reference"> 
              <a href="#referencePop30" data-trigger="click focus" data-toggle="popover" class="referencePop">[30]</a> 
              <span class="citationText" aria-hidden="true">Martínez-Zamora MÁ, Cervera R, Balasch J. Thromboembolism risk following recurrent miscarriage. Expert Rev Cardiovasc Ther. 2013 Nov;11(11):1503-13.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/24134441?tool=bestpractice.com
                 </span>

                           </span>

                           <span class="reference"> 
              <a href="#referencePop31" data-trigger="click focus" data-toggle="popover" class="referencePop">[31]</a> 
              <span class="citationText" aria-hidden="true">Heit JA, Kobbervig CE, James AH, et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005 Nov 15;143(10):697-706.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/16287790?tool=bestpractice.com
                 </span>

                           </span>

                           <span class="reference"> 
              <a href="#referencePop32" data-trigger="click focus" data-toggle="popover" class="referencePop">[32]</a> 
              <span class="citationText" aria-hidden="true">Pomp ER, Lenselink AM, Rosendaal FR, et al. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost. 2008 Apr;6(4):632-7.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://onlinelibrary.wiley.com/doi/full/10.1111/j.1538-7836.2008.02921.x
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/18248600?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-53d34474-0a08-42c3-b61e-3330a401fc3d">
                       <h3>paralysis of the lower extremities</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-53d34474-0a08-42c3-b61e-3330a401fc3d" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Venous stasis and prolonged bed rest are known to increase the risk of venous thromboembolic event.

                           <span class="reference"> 
              <a href="#referencePop34" data-trigger="click focus" data-toggle="popover" class="referencePop">[34]</a> 
              <span class="citationText" aria-hidden="true">Watson HG, Baglin TP. Guidelines on travel-related venous thrombosis. Br J Haematol. 2011 Jan;152(1):31-4.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/21083651?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-7371119f-8f5d-497d-9d49-8e42a4dd12e1">
                       <h3>factor V Leiden mutation</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-7371119f-8f5d-497d-9d49-8e42a4dd12e1" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Present in 11% to 21% of patients with a venous thromboembolic event (combined DVT/PE incident rate).

                           <span class="reference"> 
              <a href="#referencePop55" data-trigger="click focus" data-toggle="popover" class="referencePop">[55]</a> 
              <span class="citationText" aria-hidden="true">De Stefano V, Chiusolo P, Paciaroni K, et al. Epidemiology of factor V Leiden: clinical implications. Semin Thromb Hemost. 1998;24(4):367-79.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/9763354?tool=bestpractice.com
                 </span>

                           </span>

                           Heterozygous carriers have an estimated risk for venous thromboembolic event that is 7 times higher than those without the mutation. Homozygous carriers are at 80 times higher risk for venous thromboembolic event than non-affected individuals.

                           <span class="reference"> 
              <a href="#referencePop56" data-trigger="click focus" data-toggle="popover" class="referencePop">[56]</a> 
              <span class="citationText" aria-hidden="true">Rosendaal FR, Koster T, Vandenbroucke JP, et al. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood. 1995 Mar 15;85(6):1504-8.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 http://www.bloodjournal.org/content/bloodjournal/85/6/1504.full.pdf
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/7888671?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           The absolute risk of first pregnancy-associated VTE with heterozygous and homozygous factor V Leiden mutation is 1.1% and 6.2%, respectively.

                           <span class="reference"> 
              <a href="#referencePop57" data-trigger="click focus" data-toggle="popover" class="referencePop">[57]</a> 
              <span class="citationText" aria-hidden="true">Croles FN, Nasserinejad K, Duvekot JJ, et al. Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis. BMJ. 2017 Oct 26;359:j4452.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://www.bmj.com/content/359/bmj.j4452.long
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/29074563?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Patients with factor V Leiden are less likely to have a PE than are people with other inherited thrombophilias. This paradox highlights the differences that exist between the risk factors for DVT and PE.

                           <span class="reference"> 
              <a href="#referencePop58" data-trigger="click focus" data-toggle="popover" class="referencePop">[58]</a> 
              <span class="citationText" aria-hidden="true">van Langevelde K, Flinterman LE, van Hylckama Vlieg A, et al. Broadening the factor V Leiden paradox: pulmonary embolism and deep-vein thrombosis as 2 sides of the spectrum. Blood. 2012 Aug 2;120(5):933-46.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 http://www.bloodjournal.org/content/120/5/933.long
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/22496157?tool=bestpractice.com
                 </span>

                           </span>

                           <span class="reference"> 
              <a href="#referencePop59" data-trigger="click focus" data-toggle="popover" class="referencePop">[59]</a> 
              <span class="citationText" aria-hidden="true">Martinelli I, Battaglioli T, Razzari C, et al. Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia. J Thromb Haemost. 2007 Jan;5(1):98-101.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/17067362?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-2c56c3e0-37e2-4a6f-a0df-097e8171b053">
                       <h3>prothrombin G20210A mutation</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-2c56c3e0-37e2-4a6f-a0df-097e8171b053" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           The prevalence of prothrombin G20210A mutation in patients with DVT or PE varies with geography and ethnicity.

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           In North America, prothrombin gene G20210A carrier rates ranging from 1% in African-Americans to between 6.4% and 10.4% in white people have been reported among those with a history of VTE.

                           <span class="reference"> 
              <a href="#referencePop60" data-trigger="click focus" data-toggle="popover" class="referencePop">[60]</a> 
              <span class="citationText" aria-hidden="true">Dziadosz M, Baxi LV. Global prevalence of prothrombin gene mutation G20210A and implications in women&#39;s health: a systematic review. Blood Coagul Fibrinolysis. 2016 Jul;27(5):481-9.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/27058219?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           In a Dutch study, the mutation was found in 6.3% of consecutive unselected patients with a first episode of DVT.

                           <span class="reference"> 
              <a href="#referencePop61" data-trigger="click focus" data-toggle="popover" class="referencePop">[61]</a> 
              <span class="citationText" aria-hidden="true">Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3&#39;-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996 Nov 15;88(10):3698-703.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 http://www.bloodjournal.org/content/bloodjournal/88/10/3698.full.pdf
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/8916933?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Estimated to increase the risk of a venous thromboembolic event by 2 to 5 times that of those without the mutation.

                           <span class="reference"> 
              <a href="#referencePop51" data-trigger="click focus" data-toggle="popover" class="referencePop">[51]</a> 
              <span class="citationText" aria-hidden="true">Murin S, Marelich GP, Arroliga AC, et al. Hereditary thrombophilia and venous thromboembolism. Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1369-73.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://www.atsjournals.org/doi/full/10.1164/ajrccm.158.5.9712022#.UnJga1NZit8
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/9817680?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           The absolute risk of first pregnancy-associated VTE with heterozygous prothrombin G20210A mutation is 0.9%.

                           <span class="reference"> 
              <a href="#referencePop57" data-trigger="click focus" data-toggle="popover" class="referencePop">[57]</a> 
              <span class="citationText" aria-hidden="true">Croles FN, Nasserinejad K, Duvekot JJ, et al. Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis. BMJ. 2017 Oct 26;359:j4452.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://www.bmj.com/content/359/bmj.j4452.long
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/29074563?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-2d2d799a-51ee-4505-893c-8e313980acad">
                       <h3>antithrombin deficiency</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-2d2d799a-51ee-4505-893c-8e313980acad" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Large variability to the disorder. May not significantly increase the risk of thrombosis in people without a concomitant family history. Fifty percent of patients with antithrombin deficiency and a family history of thrombosis will have a venous thromboembolic event before the age of 40.

                           <span class="reference"> 
              <a href="#referencePop51" data-trigger="click focus" data-toggle="popover" class="referencePop">[51]</a> 
              <span class="citationText" aria-hidden="true">Murin S, Marelich GP, Arroliga AC, et al. Hereditary thrombophilia and venous thromboembolism. Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1369-73.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://www.atsjournals.org/doi/full/10.1164/ajrccm.158.5.9712022#.UnJga1NZit8
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/9817680?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           The absolute risk of first pregnancy-associated VTE in antithrombin-deficient women is 16.6%.

                           <span class="reference"> 
              <a href="#referencePop57" data-trigger="click focus" data-toggle="popover" class="referencePop">[57]</a> 
              <span class="citationText" aria-hidden="true">Croles FN, Nasserinejad K, Duvekot JJ, et al. Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis. BMJ. 2017 Oct 26;359:j4452.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://www.bmj.com/content/359/bmj.j4452.long
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/29074563?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-cf88c002-79ba-4d0a-928f-1558e805ba6e">
                       <h3>protein C deficiency</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-cf88c002-79ba-4d0a-928f-1558e805ba6e" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Rare inherited thrombophilia.

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           In a white population, protein C deficiency is found in approximately 2% to 5% of patients with VTE and in 5% to 10% of those with recurrent VTE.

                           <span class="reference"> 
              <a href="#referencePop62" data-trigger="click focus" data-toggle="popover" class="referencePop">[62]</a> 
              <span class="citationText" aria-hidden="true">Khan S, Dickerman JD. Hereditary thrombophilia. Thromb J. 2006 Sep 12;4:15.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://thrombosisjournal.biomedcentral.com/articles/10.1186/1477-9560-4-15
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/16968541?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           The absolute risk of first pregnancy-associated VTE in protein C-deficient women is 7.8%.

                           <span class="reference"> 
              <a href="#referencePop57" data-trigger="click focus" data-toggle="popover" class="referencePop">[57]</a> 
              <span class="citationText" aria-hidden="true">Croles FN, Nasserinejad K, Duvekot JJ, et al. Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis. BMJ. 2017 Oct 26;359:j4452.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://www.bmj.com/content/359/bmj.j4452.long
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/29074563?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-f4f17720-6f25-4a97-b763-22fce91e647a">
                       <h3>protein S deficiency</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-f4f17720-6f25-4a97-b763-22fce91e647a" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Found in 1% to 2% of patients presenting with a DVT.

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           The increase in risk associated with this disorder is not well established; the incidence of venous thromboembolic event is approximately 3.5% per year.

                           <span class="reference"> 
              <a href="#referencePop51" data-trigger="click focus" data-toggle="popover" class="referencePop">[51]</a> 
              <span class="citationText" aria-hidden="true">Murin S, Marelich GP, Arroliga AC, et al. Hereditary thrombophilia and venous thromboembolism. Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1369-73.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://www.atsjournals.org/doi/full/10.1164/ajrccm.158.5.9712022#.UnJga1NZit8
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/9817680?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           The absolute risk of first pregnancy-associated VTE in protein S-deficient women is 4.8%.

                           <span class="reference"> 
              <a href="#referencePop57" data-trigger="click focus" data-toggle="popover" class="referencePop">[57]</a> 
              <span class="citationText" aria-hidden="true">Croles FN, Nasserinejad K, Duvekot JJ, et al. Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis. BMJ. 2017 Oct 26;359:j4452.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://www.bmj.com/content/359/bmj.j4452.long
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/29074563?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-1ff90ac4-a70f-42b8-b79f-44092d54ce2a">
                       <h3>antiphospholipid antibody syndrome</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-1ff90ac4-a70f-42b8-b79f-44092d54ce2a" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Antiphospholipid antibodies have been reported in up to 14% of patients presenting with a VTE.

                           <span class="reference"> 
              <a href="#referencePop63" data-trigger="click focus" data-toggle="popover" class="referencePop">[63]</a> 
              <span class="citationText" aria-hidden="true">Ortel TL. Thrombosis and the antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program. 2005:462-8.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 http://asheducationbook.hematologylibrary.org/content/2005/1/462.long
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/16304421?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

           </div>
           <div class="container strong">

               <div class="row rowHead">
                   <h3 id="rfs-weak" class="col-md-12">
                          <a href="#">
                             <span>weak</span>
                             <span class="hidden-sm-down">
                                <span class="msg">VIEW ALL</span>
                                <span class="material-icons" role="button"><span>&#xE313;</span><span>&#xE316;</span></span>
                             </span>
                          </a>
                       </h3>
               </div>

               <!-- this is a list of risk factors -->

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-7a68c8df-1230-4da9-90d8-50465bb3b6f3">
                       <h3>obesity (BMI ≥29 kg/m²)</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-7a68c8df-1230-4da9-90d8-50465bb3b6f3" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Present in 29% of patients with a diagnosed PE.

                           <span class="reference"> 
              <a href="#referencePop19" data-trigger="click focus" data-toggle="popover" class="referencePop">[19]</a> 
              <span class="citationText" aria-hidden="true">Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999 Apr 24;353(9162):1386-9.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/10227218?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           More likely to be present in patients who die from PE.

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-522ceefe-361b-4318-8652-cab54f90c578">
                       <h3>cigarette smoking</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-522ceefe-361b-4318-8652-cab54f90c578" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Current smoking modestly increases the risk of VTE (hazard ratio [HR] 1.19, 95% CI 1.08 to 1.32).

                           <span class="reference"> 
              <a href="#referencePop23" data-trigger="click focus" data-toggle="popover" class="referencePop">[23]</a> 
              <span class="citationText" aria-hidden="true">Mahmoodi BK, Cushman M, Anne Næss I, et al. Association of traditional cardiovascular risk factors with venous thromboembolism: an individual participant data meta-analysis of prospective studies. Circulation. 2017 Jan 3;135(1):7-16.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 http://circ.ahajournals.org/content/135/1/7.long
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/27831499?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Subtype analyses indicate that smoking is associated with provoked (but not unprovoked) VTE, possibly through comorbid conditions such as cancer.

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Present in 18% with confirmed PE.

                           <span class="reference"> 
              <a href="#referencePop19" data-trigger="click focus" data-toggle="popover" class="referencePop">[19]</a> 
              <span class="citationText" aria-hidden="true">Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999 Apr 24;353(9162):1386-9.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/10227218?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-d962ef3d-f81f-4821-8cef-59874f7ae003">
                       <h3>chronic obstructive pulmonary disease (COPD)</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-d962ef3d-f81f-4821-8cef-59874f7ae003" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Patients with stage III/IV COPD have a higher risk of VTE compared with those without COPD (HR 1.61, 95% CI 0.90 to 2.93).

                           <span class="reference"> 
              <a href="#referencePop24" data-trigger="click focus" data-toggle="popover" class="referencePop">[24]</a> 
              <span class="citationText" aria-hidden="true">Børvik T, Brækkan SK, Enga K, et al. COPD and risk of venous thromboembolism and mortality in a general population. Eur Respir J. 2016 Feb;47(2):473-81.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 http://erj.ersjournals.com/content/47/2/473.long
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/26585434?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           COPD severity (defined by airflow limitation or medication usage), rather than frequency of exacerbations, may be associated with VTE events in people with COPD.

                           <span class="reference"> 
              <a href="#referencePop25" data-trigger="click focus" data-toggle="popover" class="referencePop">[25]</a> 
              <span class="citationText" aria-hidden="true">Morgan AD, Herrett E, De Stavola BL, et al. COPD disease severity and the risk of venous thromboembolic events: a matched case-control study. Int J Chron Obstruct Pulmon Dis. 2016 Apr 28;11:899-908.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://www.dovepress.com/copd-disease-severity-and-the-risk-of-venous-thromboembolic-events-a-m-peer-reviewed-fulltext-article-COPD
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/27175072?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Present in 12% with confirmed PE.

                           <span class="reference"> 
              <a href="#referencePop19" data-trigger="click focus" data-toggle="popover" class="referencePop">[19]</a> 
              <span class="citationText" aria-hidden="true">Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999 Apr 24;353(9162):1386-9.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/10227218?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-e6539372-2256-47f1-b2ea-d1a22aca043f">
                       <h3>congestive heart failure (CHF)</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-e6539372-2256-47f1-b2ea-d1a22aca043f" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           CHF is an independent risk factor for VTE.

                           <span class="reference"> 
              <a href="#referencePop26" data-trigger="click focus" data-toggle="popover" class="referencePop">[26]</a> 
              <span class="citationText" aria-hidden="true">Heit JA, O&#39;Fallon WM, Petterson TM, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med. 2002 Jun 10;162(11):1245-8.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/211541
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/12038942?tool=bestpractice.com
                 </span>

                           </span>

                           It is present in 10% with confirmed PE.

                           <span class="reference"> 
              <a href="#referencePop19" data-trigger="click focus" data-toggle="popover" class="referencePop">[19]</a> 
              <span class="citationText" aria-hidden="true">Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999 Apr 24;353(9162):1386-9.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/10227218?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Death certificate data from the United States Census Bureau list PE as the cause of death among 2.7% of adults (20,387 of 755,807) who died with heart failure between 1980 and 1998.

                           <span class="reference"> 
              <a href="#referencePop27" data-trigger="click focus" data-toggle="popover" class="referencePop">[27]</a> 
              <span class="citationText" aria-hidden="true">Beemath A, Skaf E, Stein PD. Pulmonary embolism as a cause of death in adults who died with heart failure. Am J Cardiol. 2006 Oct 15;98(8):1073-5.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/17027574?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-1cf5877c-f37e-4fec-aabf-7e8a046c7790">
                       <h3>central venous catheterisation</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-1cf5877c-f37e-4fec-aabf-7e8a046c7790" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Studies of cancer patients have estimated the overall rate of catheter-related thrombosis to be between 14% and 18%.

                           <span class="reference"> 
              <a href="#referencePop28" data-trigger="click focus" data-toggle="popover" class="referencePop">[28]</a> 
              <span class="citationText" aria-hidden="true">Murray J, Precious E, Alikhan R. Catheter-related thrombosis in cancer patients. Br J Haematol. 2013 Sep;162(6):748-57.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://onlinelibrary.wiley.com/doi/full/10.1111/bjh.12474
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/23848991?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Among non-metastatic invasive breast cancer patients, an incidence rate of 2.18/100 patient-months has been reported for central venous catheter-related VTE.

                           <span class="reference"> 
              <a href="#referencePop29" data-trigger="click focus" data-toggle="popover" class="referencePop">[29]</a> 
              <span class="citationText" aria-hidden="true">Debourdeau P, Espié M, Chevret S, et al. Incidence, risk factors, and outcomes of central venous catheter-related thromboembolism in breast cancer patients: the CAVECCAS study. Cancer Med. 2017 Nov;6(11):2732-44.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://onlinelibrary.wiley.com/doi/full/10.1002/cam4.1201
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/28980454?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-47bfec05-ac9b-430b-9f7f-4b2452402583">
                       <h3>varicose veins</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-47bfec05-ac9b-430b-9f7f-4b2452402583" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Risk of incident DVT is significantly increased in people with varicose veins compared with those without (6.55 vs 1.23 per 1000 person-years).

                           <span class="reference"> 
              <a href="#referencePop33" data-trigger="click focus" data-toggle="popover" class="referencePop">[33]</a> 
              <span class="citationText" aria-hidden="true">Chang SL, Huang YL, Lee MC, et al. Association of varicose veins with incident venous thromboembolism and peripheral artery disease. JAMA. 2018 Feb 27;319(8):807-17.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/29486040?tool=bestpractice.com
                 </span>

                           </span>

                           Findings regarding PE are less clear.

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-e4f9e77c-639e-4f49-acd3-a739083d4e4b">
                       <h3>recent air travel</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-e4f9e77c-639e-4f49-acd3-a739083d4e4b" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Long-duration travel is a weak risk factor for the development of VTE.

                           <span class="reference"> 
              <a href="#referencePop34" data-trigger="click focus" data-toggle="popover" class="referencePop">[34]</a> 
              <span class="citationText" aria-hidden="true">Watson HG, Baglin TP. Guidelines on travel-related venous thrombosis. Br J Haematol. 2011 Jan;152(1):31-4.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/21083651?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           The incidence of VTE in flights &gt;8 hours&#39; duration is approximately 0.5% in travellers at low to intermediate risk for development of VTE.

                           <span class="reference"> 
              <a href="#referencePop34" data-trigger="click focus" data-toggle="popover" class="referencePop">[34]</a> 
              <span class="citationText" aria-hidden="true">Watson HG, Baglin TP. Guidelines on travel-related venous thrombosis. Br J Haematol. 2011 Jan;152(1):31-4.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/21083651?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Multiple pathophysiological factors have been attributed to increased risk including immobility, relative hypoxia in the pressure-controlled cabin, and dehydration.

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Individual risk factors for air travel-related VTE also play an important role. Age &gt;40 years, female sex, women who use oral contraceptives, people with chronic venous insufficiency and/or varicose veins in the lower limbs, obesity, and genetic thrombophilia are strong modulators of VTE attributed to long-distance flights.

                           <span class="reference"> 
              <a href="#referencePop35" data-trigger="click focus" data-toggle="popover" class="referencePop">[35]</a> 
              <span class="citationText" aria-hidden="true">Gavish I, Brenner B. Air travel and the risk of thromboembolism. Intern Emerg Med. 2011 Apr;6(2):113-6.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/21057984?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-1b24ef81-d748-4cd0-aac3-00d820f63cc2">
                       <h3>history of spontaneous abortion</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-1b24ef81-d748-4cd0-aac3-00d820f63cc2" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Acquired thrombophilic factors related to arterial and/or venous thrombosis are associated with recurrent miscarriage.

                           <span class="reference"> 
              <a href="#referencePop30" data-trigger="click focus" data-toggle="popover" class="referencePop">[30]</a> 
              <span class="citationText" aria-hidden="true">Martínez-Zamora MÁ, Cervera R, Balasch J. Thromboembolism risk following recurrent miscarriage. Expert Rev Cardiovasc Ther. 2013 Nov;11(11):1503-13.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/24134441?tool=bestpractice.com
                 </span>

                           </span>

                           <span class="reference"> 
              <a href="#referencePop36" data-trigger="click focus" data-toggle="popover" class="referencePop">[36]</a> 
              <span class="citationText" aria-hidden="true">Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e691S-736S.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://journal.chestnet.org/article/S0012-3692(12)60136-6/fulltext
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/22315276?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-71d15cf3-16eb-40c7-b0a8-3adf7a26fdad">
                       <h3>recent acute myocardial infarction</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-71d15cf3-16eb-40c7-b0a8-3adf7a26fdad" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Registry studies variously report that myocardial infarction is associated with a transient increased risk of VTE, independent of atherosclerotic risk factors, or that it is not an independent risk factor for VTE.

                           <span class="reference"> 
              <a href="#referencePop37" data-trigger="click focus" data-toggle="popover" class="referencePop">[37]</a> 
              <span class="citationText" aria-hidden="true">Rinde LB, Lind C, Småbrekke B, et al. Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study. J Thromb Haemost. 2016 Jun;14(6):1183-91.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://onlinelibrary.wiley.com/doi/full/10.1111/jth.13329
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/27061154?tool=bestpractice.com
                 </span>

                           </span>

                           <span class="reference"> 
              <a href="#referencePop38" data-trigger="click focus" data-toggle="popover" class="referencePop">[38]</a> 
              <span class="citationText" aria-hidden="true">Barsoum MK, Cohoon KP, Roger VL, et al. Are myocardial infarction and venous thromboembolism associated? Population-based case-control and cohort studies. Thromb Res. 2014 Sep;134(3):593-8.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142114/
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/25037496?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-d4c143c2-0d9e-4308-b0f8-f41be58ce7c1">
                       <h3>sepsis</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-d4c143c2-0d9e-4308-b0f8-f41be58ce7c1" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           In a small prospective study of patients with severe sepsis and septic shock, VTE incidence was 37.2% despite thromboprophylaxis.

                           <span class="reference"> 
              <a href="#referencePop39" data-trigger="click focus" data-toggle="popover" class="referencePop">[39]</a> 
              <span class="citationText" aria-hidden="true">Kaplan D, Casper TC, Elliott CG, et al. VTE incidence and risk factors in patients with severe sepsis and septic shock. Chest. 2015 Nov;148(5):1224-30.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631038/
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/26111103?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           A prospective cohort study using data from the National Surgical Quality Improvement Program database of the American College of Surgeons (ACS-NSQIP) found that preoperative sepsis in patients undergoing a surgical procedure increased the risk of postoperative venous thrombosis compared with patients without any systemic inflammation (odds ratio [OR] 3.3, 95% CI 3.2 to 3.4).

                           <span class="reference"> 
              <a href="#referencePop40" data-trigger="click focus" data-toggle="popover" class="referencePop">[40]</a> 
              <span class="citationText" aria-hidden="true">Donzé JD, Ridker PM, Finlayson SR, et al. Impact of sepsis on risk of postoperative arterial and venous thromboses: large prospective cohort study. BMJ. 2014 Sep 8;349:g5334.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://www.bmj.com/content/349/bmj.g5334.long
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/25199629?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-c940e5ef-a58b-4174-9e4e-24580a0e0928">
                       <h3>recent blood transfusion</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-c940e5ef-a58b-4174-9e4e-24580a0e0928" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Transfusion of red blood cells, platelets, and fresh frozen plasma is associated with an increased risk of venous and arterial thrombotic events and mortality in hospitalised patients with cancer, acute coronary syndrome, or acute bleeding.

                           <span class="reference"> 
              <a href="#referencePop41" data-trigger="click focus" data-toggle="popover" class="referencePop">[41]</a> 
              <span class="citationText" aria-hidden="true">Khorana AA, Francis CW, Blumberg N, et al. Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch Intern Med. 2008 Nov 24;168(21):2377-81.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/414655
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/19029504?tool=bestpractice.com
                 </span>

                           </span>

                           <span class="reference"> 
              <a href="#referencePop42" data-trigger="click focus" data-toggle="popover" class="referencePop">[42]</a> 
              <span class="citationText" aria-hidden="true">Doyle BJ, Rihal CS, Gastineau DA, et al. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice. J Am Coll Cardiol. 2009 Jun 2;53(22):2019-27.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 http://www.onlinejacc.org/content/53/22/2019
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/19477350?tool=bestpractice.com
                 </span>

                           </span>

                           <span class="reference"> 
              <a href="#referencePop43" data-trigger="click focus" data-toggle="popover" class="referencePop">[43]</a> 
              <span class="citationText" aria-hidden="true">Xenos ES, Vargas HD, Davenport DL. Association of blood transfusion and venous thromboembolism after colorectal cancer resection. Thromb Res. 2012 May;129(5):568-72.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/21872295?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-046ac319-3b00-4ac8-8e2b-5153ae483f25">
                       <h3>combined hormonal contraception</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-046ac319-3b00-4ac8-8e2b-5153ae483f25" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Current exposure to a combined oral contraceptive (COC) is associated with an increased risk of VTE (adjusted OR 2.97, 95% CI 2.78 to 3.17) compared with no exposure during the previous year.

                           <span class="reference"> 
              <a href="#referencePop44" data-trigger="click focus" data-toggle="popover" class="referencePop">[44]</a> 
              <span class="citationText" aria-hidden="true">Vinogradova Y, Coupland C, Hippisley-Cox J. Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. 2015 May 26;350:h2135.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://www.bmj.com/content/350/bmj.h2135.long
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/26013557?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           The risk of VTE associated with different COCs appears to be influenced by progestogen type. COCs containing levonorgestrel, norethisterone, or norgestimate have the lowest risk (5-7 events per 10,000 women per year), whereas those containing drospirenone, desogestrel, or gestodene have the highest risk (9-12 events per 10,000 women per year).

                           <span class="web-link-wrap"> 
              <a rel="external" target="_blank" href="http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Combined_hormonal_contraceptives/human_referral_prac_000016.jsp&amp;mid=WC0b01ac05805c516f">
                 European Medicines Agency: combined hormonal contraceptives
                 <span class="icon icon-bp-icons-outbound-link"></span>
                           </a>
                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Observational studies of the combined ethinylestradiol and norelgestromin transdermal patch have reported a similar, or increased, level of VTE risk compared with COCs containing second-generation progestogens.

                           <span class="web-link-wrap"> 
              <a rel="external" target="_blank" href="https://www.fsrh.org/standards-and-guidance/documents/fsrhstatementvteandhormonalcontraception-november/">
                 Faculty of Sexual &amp; Reproductive Healthcare: statement - venous thromboembolism (VTE) and hormonal contraception
                 <span class="icon icon-bp-icons-outbound-link"></span>
                           </a>
                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Progestogen-only methods of contraception do not appear to be associated with an increased risk of VTE.

                           <span class="web-link-wrap"> 
              <a rel="external" target="_blank" href="https://www.fsrh.org/standards-and-guidance/documents/fsrhstatementvteandhormonalcontraception-november/">
                 Faculty of Sexual &amp; Reproductive Healthcare: statement - venous thromboembolism (VTE) and hormonal contraception
                 <span class="icon icon-bp-icons-outbound-link"></span>
                           </a>
                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-35b86bd5-3799-4e03-9328-6f8e7f3d60e0">
                       <h3>oral hormone replacement therapy (HRT)</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-35b86bd5-3799-4e03-9328-6f8e7f3d60e0" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Oral HRT preparations containing oestrogen, or combined oestrogen-progestogen, increase the risk of VTE.

                           <span class="reference"> 
              <a href="#referencePop45" data-trigger="click focus" data-toggle="popover" class="referencePop">[45]</a> 
              <span class="citationText" aria-hidden="true">Renoux C, Dell&#39;Aniello S, Suissa S. Hormone replacement therapy and the risk of venous thromboembolism: a population-based study. J Thromb Haemost. 2010 May;8(5):979-86.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://onlinelibrary.wiley.com/doi/full/10.1111/j.1538-7836.2010.03839.x
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/20230416?tool=bestpractice.com
                 </span>

                           </span>

                           Risk is greater with increased oestrogen dose.

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-44240bdd-58a8-45a8-93d4-55937883c991">
                       <h3>inflammatory bowel disease</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-44240bdd-58a8-45a8-93d4-55937883c991" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           The risk of VTE is increased in patients with inflammatory bowel disease compared with those who do not have inflammatory bowel disease.

                           <span class="reference"> 
              <a href="#referencePop46" data-trigger="click focus" data-toggle="popover" class="referencePop">[46]</a> 
              <span class="citationText" aria-hidden="true">Nguyen GC, Bernstein CN, Bitton A, et al. Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology. Gastroenterology. 2014 Mar;146(3):835-48.e6.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://www.gastrojournal.org/article/S0016-5085(14)00101-2/fulltext
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/24462530?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           More likely to be seen in those who die with a PE, with an adjusted mortality ratio double that of unaffected individuals.

                           <span class="reference"> 
              <a href="#referencePop18" data-trigger="click focus" data-toggle="popover" class="referencePop">[18]</a> 
              <span class="citationText" aria-hidden="true">Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Arch Intern Med. 2003 Jul 28;163(14):1711-7.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/215882
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/12885687?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Serological abnormalities found in inactive Crohn&#39;s disease and ulcerative colitis, including abnormalities in fibrinolysis, may increase risk of PE.

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-d14a14dd-b9e7-407e-b642-c489f2025cb4">
                       <h3>nephrotic syndrome</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-d14a14dd-b9e7-407e-b642-c489f2025cb4" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Nephrotic syndrome increased the risk of VTE in a case-control study (OR 2.89, 95% CI 2.26 to 3.69).

                           <span class="reference"> 
              <a href="#referencePop47" data-trigger="click focus" data-toggle="popover" class="referencePop">[47]</a> 
              <span class="citationText" aria-hidden="true">Christiansen CF, Schmidt M, Lamberg AL, et al. Kidney disease and risk of venous thromboembolism: a nationwide population-based case-control study. J Thromb Haemost. 2014 Sep;12(9):1449-54.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://onlinelibrary.wiley.com/doi/full/10.1111/jth.12652
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/25040558?tool=bestpractice.com
                 </span>

                           </span>

                           The association was strongest within the first 3 months.

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Severe nephrotic syndrome leads to hypercoagulability, resulting in thromboembolism at sites such as the renal and pulmonary vasculature.

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-390bdd97-918c-4836-ab0a-23fef77adfcc">
                       <h3>Behcet&#39;s disease</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-390bdd97-918c-4836-ab0a-23fef77adfcc" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Estimates of thrombotic events in Behcet&#39;s disease vary from 10% to 30%.

                           <span class="reference"> 
              <a href="#referencePop48" data-trigger="click focus" data-toggle="popover" class="referencePop">[48]</a> 
              <span class="citationText" aria-hidden="true">Tomasson G, Monach PA, Merkel PA. Thromboembolic disease in vasculitis. Curr Opin Rheumatol. 2009 Jan;21(1):41-6.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204384/
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/19077717?tool=bestpractice.com
                 </span>

                           </span>

                           VTEs appear to be more common in males.

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           An 8-year audit in one hospital in Turkey found that venous thromboembolic events occurred in 12.8% of patients with the disease.

                           <span class="reference"> 
              <a href="#referencePop49" data-trigger="click focus" data-toggle="popover" class="referencePop">[49]</a> 
              <span class="citationText" aria-hidden="true">Kuzu MA, Ozaslan C, Köksoy C, et al. Vascular involvement in Behcet&#39;s disease: 8-year audit. World J Surg. 1994 Nov-Dec;18(6):948-53.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/7846925?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           This association may be linked to hyperhomocysteinaemia.

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-7801f8c3-1ed7-4b0d-ba1f-88f976a2d2aa">
                       <h3>homocysteinaemia</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-7801f8c3-1ed7-4b0d-ba1f-88f976a2d2aa" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Prospective studies indicate that hyperhomocysteinaemia is associated with increased risk of VTE.

                           <span class="reference"> 
              <a href="#referencePop50" data-trigger="click focus" data-toggle="popover" class="referencePop">[50]</a> 
              <span class="citationText" aria-hidden="true">Herrmann M, Whiting MJ, Veillard AS, et al. Plasma homocysteine and the risk of venous thromboembolism: insights from the FIELD study. Clin Chem Lab Med. 2012 Dec;50(12):2213-9.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/23093273?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Homocysteinaemia may increase the relative risk of venous thromboembolic event 2.5-fold.

                           <span class="reference"> 
              <a href="#referencePop51" data-trigger="click focus" data-toggle="popover" class="referencePop">[51]</a> 
              <span class="citationText" aria-hidden="true">Murin S, Marelich GP, Arroliga AC, et al. Hereditary thrombophilia and venous thromboembolism. Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1369-73.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://www.atsjournals.org/doi/full/10.1164/ajrccm.158.5.9712022#.UnJga1NZit8
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/9817680?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                       <p class="w-75">
                           <!-- col-md-9 -->

                           One pooled analysis of case-control and cohort studies found that the methylenetetrahydrofolate reductase (MTHFR) C677T genetic variant (encoding a thermolabile enzyme that is less active at higher temperatures) is not independently associated with VTE risk.

                           <span class="reference"> 
              <a href="#referencePop52" data-trigger="click focus" data-toggle="popover" class="referencePop">[52]</a> 
              <span class="citationText" aria-hidden="true">Simone B, De Stefano V, Leoncini E, et al. Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol. 2013 Aug;28(8):621-47.</span>
                           <span class="citationFullTextUrl" aria-hidden="true">
                 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935237/
              </span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/23900608?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

               <div class="row rowCondition">
                   <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseFactor-9fb85069-a9e5-4b74-87fb-f8c1f8e71004">
                       <h3>Philadelphia-negative myeloproliferative neoplasms</h3>
                   </div>
               </div>
               <div class="row rowDetails">
                   <div id="collapseFactor-9fb85069-a9e5-4b74-87fb-f8c1f8e71004" class="collapse col-md-12">

                       <p class="w-75">
                           <!-- col-md-9 -->

                           Studies demonstrate a significant association between JAK2V617F allele burden and venous thromboembolic events in patients with Philadelphia-negative myeloproliferative neoplasms.

                           <span class="reference"> 
              <a href="#referencePop53" data-trigger="click focus" data-toggle="popover" class="referencePop">[53]</a> 
              <span class="citationText" aria-hidden="true">Borowczyk M, Wojtaszewska M, Lewandowski K, et al. The JAK2 V617F mutational status and allele burden may be related with the risk of venous thromboembolic events in patients with Philadelphia-negative myeloproliferative neoplasms. Thromb Res. 2015 Feb;135(2):272-80.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/25559461?tool=bestpractice.com
                 </span>

                           </span>

                           <span class="reference"> 
              <a href="#referencePop54" data-trigger="click focus" data-toggle="popover" class="referencePop">[54]</a> 
              <span class="citationText" aria-hidden="true">Ball S, Thein KZ, Maiti A, et al. Thrombosis in Philadelphia negative classical myeloproliferative neoplasms: a narrative review on epidemiology, risk assessment, and pathophysiologic mechanisms. J Thromb Thrombolysis. 2018 May;45(4):516-28.</span>

                           <span class="referenceUniqueId" aria-hidden="true">
                    http://www.ncbi.nlm.nih.gov/pubmed/29404876?tool=bestpractice.com
                 </span>

                           </span>

                       </p>

                   </div>
               </div>

           </div>
       </div>
   </div>

</div>
<!-- NEW RF FROM LIVE ENDS -->


         <div class="card-block disclaimer">
            <p><span>Use of this content is subject to our <a href="https://bestpractice.bmj.com/info/disclaimer/" target="_blank">disclaimer</a> </span></p>
         </div>
      </main>
      <script type="text/javascript" id="">(function(){var f=google_tag_manager["GTM-K3TZ3JV"].macro(4),b=google_tag_manager["GTM-K3TZ3JV"].macro(5),a=function(a,b,d){var e="",c=new Date;d&&(c.setTime(c.getTime()+864E5*d),e="; expires\x3d"+c.toGMTString());document.cookie=a+"\x3d"+b+e+"; path\x3d/; domain\x3dbmj.com"};f?"true"!=b&&("justLoggedIn"==b?a("loggedIn","true",2):a("loggedIn","justLoggedIn",2)):a("loggedIn","false",2)})();</script>
      <!-- set the messages country code variable from region to be used from i18 plugin. Setting here so it's available in all pages -->
      <script>
         /*<![CDATA[*/
         
         var messagesCountryCode = "en_GB";
         /*]]>*/
           
      </script>
      <aside id="panel-nhs" class="card-block">
         <div id="access" class="col-sm-6">
            <div class="row">
               <div class="col-md-6">
                  <p>Access provided by:</p>
               </div>
               <div class="col-md-6">
                  <img src="../images/bmj-logo.png" alt="BMJ Group (Online access from BMA House)">
               </div>
            </div>
         </div>
      </aside>
      <footer id="footer">
         <div class="container">
            <div class="row">
               <nav class="col-md-9" role="navigation">
                  <div class="row">
                     <dl class="col-md-4" role="menu">
                        <dt>Browse</dt>
                        <dd><a href="https://bestpractice.bmj.com/">Home</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/recent-updates">Recent updates</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/specialties">Specialties</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/calculators">Calculators</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/patient-leaflets">Patient leaflets</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/procedural-videos">Procedural videos</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/evidence">Evidence</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/drugs">Drugs</a></dd>
                     </dl>
                     <!-- logged-in individual or institutional user -->
                     <!-- unknown user -->
                     <!--institutional user not logged in-->
                     <dl class="col-md-4" role="menu">
                        <dt>Services</dt>
                        <dd><a href="https://bestpractice.bmj.com/login">Log in</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/registration">Create an account</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/getting-started/" target="_blank">Getting started</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/faq/" target="_blank">FAQs</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/benefits-features/earn-cme-points/" target="_blank">About CME/CPD</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/benefits-features/" target="_blank">About us</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/app/" target="_blank">Mobile app</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/contact-us/" target="_blank">Contact us</a></dd>
                        <dd>
                           <a href="https://myaccount.bmj.com/myaccount/registration.html?regService=bestpractice-email-alert&amp;fwdUrl=https://bestpractice.bmj.com">
                           Sign up for email alerts
                           </a>
                        </dd>
                     </dl>
                     <dl class="col-md-4" role="menu">
                        <dt>Legal</dt>
                        <dd><a href="https://bestpractice.bmj.com/info/disclaimer/" target="_blank">Disclaimer</a></dd>
                        <dd><a href="https://www.bmj.com/company/legal-information/" target="_blank">Terms and conditions</a></dd>
                        <dd><a href="https://www.bmj.com/company/your-privacy/" target="_blank">Privacy notice</a></dd>
                        <dd><a href="https://www.bmj.com/company/your-privacy/cookies-policy/" target="_blank">Cookie policy</a></dd>
                     </dl>
                  </div>
                  <!-- row -->
               </nav>
               <div class="col-md-3">
                  <ul>
                     <li><a target="_blank" href="https://www.facebook.com/BMJBestPractice"><img alt="Facebook Logo" title="Facebook" src="../images/facebook-64.png" width="60" height="60"></a></li>
                     <li><a target="_blank" href="https://twitter.com/BMJBestPractice"><img alt="Twiter Logo" title="Twitter" src="../images/twitter-64.png" width="60" height="60"></a></li>
                     <li><a target="_blank" href="https://www.linkedin.com/showcase/15218227/"><img alt="LinkedIn Logo" title="LinkedIn" src="../images/linkedIn_logo_circle.png" width="60" height="60"></a></li>
                     <li><a target="_blank" href="https://www.youtube.com/channel/UCt72GZ0cPXpk4EzgFhdWYdQ"><img alt="Youtube Logo" title="YouTube" src="../images/youtube-64.png" width="60" height="60"></a></li>
                  </ul>
                  <p class="copyright mt-3"><small>© BMJ Publishing Group 2018</small></p>
                  <p class="issn"><small>ISSN 2515-9615</small></p>
               </div>
            </div>
            <!-- row -->  
         </div>
         <!-- container -->    
      </footer>
      <div class="container modal-registration-form" aria-hidden="true">
         <div id="feedbackContainer" class="modal fade" tabindex="-1" role="dialog" aria-labelledby="ModalFeedbackLabel" aria-hidden="true">
            <div class="modal-dialog modal-lg" role="document">
               <div class="modal-content pb-3">
                  <div class="modal-header">
                     <div class="row">
                        <div class="col-md-12">
                           <h2>Help us improve <abbr>BMJ</abbr> Best Practice</h2>
                           <button type="button" class="close" data-dismiss="modal" aria-label="Close">
                           <span aria-hidden="true">×</span>
                           </button>
                        </div>
                        <div class="col-md-12">
                           <p>Please complete all fields.</p>
                        </div>
                     </div>
                  </div>
                  <div class="modal-body">
                     <div class="row">
                        <div class="col-md-12">
                           <form id="feedbackForm" action="https://bestpractice.bmj.com/topics/en-gb/116/epidemiology#" novalidate="novalidate">
                              <div class="row">
                                 <div class="col-md-6">
                                    <div class="form-group floating-label">
                                       <label for="feedbackName">Name</label> 
                                       <input id="feedbackName" class="form-control" name="feedbackName" type="text">
                                    </div>
                                 </div>
                                 <div class="col-md-6">
                                    <div class="form-group floating-label">
                                       <label for="feedbackEmail">Email</label> 
                                       <input id="feedbackEmail" class="form-control" name="feedbackEmail" type="email" value="">
                                    </div>
                                 </div>
                              </div>
                              <div class="row">
                                 <div class="col-md-12">
                                    <h2 id="feedbackPageTitle" class="h3">Page: Pulmonary embolism - Epidemiology | BMJ Best Practice</h2>
                                 </div>
                              </div>
                              <input id="feedbackPage" name="feedbackPage" type="hidden" value="Pulmonary embolism - Epidemiology | BMJ Best Practice">
                              <div class="row">
                                 <div class="col-md-4">
                                    <p>I have some feedback on:</p>
                                    <fieldset class="form-group" role="radiogroup">
                                       <legend>Feedback on: </legend>
                                       <label for="feedOn01"><input id="feedOn01" type="radio" name="feedbackOn" value="This page" checked="checked">&nbsp;This page</label>
                                       <label for="feedOn02"><input id="feedOn02" type="radio" name="feedbackOn" value="This website">&nbsp;The website in general</label>
                                       <label for="feedOn03"><input id="feedOn03" type="radio" name="feedbackOn" value="Something else">&nbsp;Something else</label>
                                    </fieldset>
                                 </div>
                                 <div class="col-md-8">
                                    <div class="form-group floating-label textarea">
                                       <label for="feedbackContent">I have some feedback on:</label>
                                       <textarea id="feedbackContent" name="feedbackContent"></textarea>
                                    </div>
                                 </div>
                              </div>
                              <div class="row">
                                 <div class="col-md-12">
                                    <p>We will respond to all feedback.</p>
                                 </div>
                              </div>
                              <div class="row">
                                 <div class="col-md-12">
                                    <button id="feedbackSubmit" type="submit" class="btn btn-secondary btn-lg">
                                    <span id="spinner2" class="progress-circular-inner progress-circular-left"></span>
                                    <span id="btnText2">Submit Feedback</span>
                                    </button>
                                 </div>
                              </div>
                              <div class="row smTxt">
                                 <div class="col-md-12">
                                    <p>For any urgent enquiries please contact our customer services team who are ready to help with any problems.</p>
                                 </div>
                              </div>
                              <div class="row smTxt">
                                 <div class="col-md-3">
                                    <p><b>Phone:</b> +44 (0) 207 111 1105</p>
                                 </div>
                                 <div class="col-md-3">
                                    <p><b>Email: </b> <a href="mailto:support@bmj.com">support@bmj.com</a></p>
                                 </div>
                              </div>
                           </form>
                        </div>
                     </div>
                  </div>
               </div>
            </div>
         </div>
         <div id="feedbackSuccess" class="modal fade" tabindex="-1" role="dialog" aria-labelledby="ModalFeedbackConfirmedLabel" aria-hidden="true">
            <div class="modal-dialog modal-lg" role="document">
               <div class="modal-content pb-3">
                  <div class="modal-body">
                     <div class="row">
                        <div class="col-md-12">
                           <h2>Thank you</h2>
                           <button type="button" class="close" data-dismiss="modal" aria-label="Close">
                           <span aria-hidden="true">×</span>
                           </button>
                        </div>
                     </div>
                     <div class="row">
                        <div class="col-md-12">
                           <p>Your feedback has been submitted successfully.</p>
                        </div>
                     </div>
                  </div>
               </div>
            </div>
         </div>
         <div id="feedBackBtn">
            <p role="button"><a href="https://bestpractice.bmj.com/topics/en-gb/116/epidemiology#"><span class="material-icons"></span>&nbsp;FEEDBACK</a></p>
         </div>
      </div>
      <script type="text/javascript" src="../js/common.js"></script>
      <script type="text/javascript" src="../js/main.js"></script>
      <script>
         // Code for the recently viewed topics suggestion, needs to be inlined to use the Java values
         /*<![CDATA[*/       
         function dedupe(array) {
           var seen = {};
           return array.filter(function(item) {
               return seen.hasOwnProperty(item.id) ? false : (seen[item.id] = true);
           });
         }
         function TopicViewed(id, title, lang) {
           this.id = id;
           this.title = title;
           this.lang = lang;
         }
         jQuery(document).ready(function() {
           var topicId = 116;
           var topicLang = "en-gb";
           var topicTitle = "Pulmonary embolism";
           if(topicId){
               
             var topicsViewed = [];
             if (localStorage.getItem("topicsViewed") !== null) {
               topicsViewed = JSON.parse(localStorage.topicsViewed);
             }
               
             topicsViewed.unshift(new TopicViewed(topicId, topicTitle, topicLang));// Add new topics at the beginning
             topicsViewed = dedupe(topicsViewed);// Remove duplicates
             if (topicsViewed.length > 15){// Drop if size is bigger than 15
               topicsViewed = topicsViewed.slice(0,14);  
             }
         
             localStorage.topicsViewed = JSON.stringify(topicsViewed);
           }
          });       
         /*]]>*/
      </script>
      <script type="text/javascript">
         _linkedin_data_partner_id = "103646";
      </script>
      <script type="text/javascript">
         (function()
         {var s = document.getElementsByTagName("script")[0]; var b = document.createElement("script"); b.type = "text/javascript";b.async = true; b.src = "https://snap.licdn.com/li.lms-analytics/insight.min.js"; s.parentNode.insertBefore(b, s);}
         )();
      </script>
      <script type="text/javascript" data-cfasync="false">
         (function(W,i,s,e,P,o,p){W['WisePopsObject']=P;W[P]=W[P]||function()
         { (W[P].q=W[P].q||[]).push(arguments)}
         ,W[P].l=1*new Date();o=i.createElement(s),
         p=i.getElementsByTagName(s)[0];o.async=1;o.src=e;p.parentNode.insertBefore(o,p)
         })(window,document,'script','//loader.wisepops.com/get-loader.js?v=1&site=qudyiEfMBd','wisepops');
         window.WisePopsLoaderCallback = function(wisepops) {
                         wisepops._storage.visits = wisepops._storage.visits.slice(0, 2);
                         wisepops._storage._saveVisits();
                       };
      </script>
      <noscript>
         <img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=103646&fmt=gif" />
      </noscript>
      <!--[if lte IE 7]><script>var isIE7OrOlder = true; </script><![endif]-->   
      <!--[if lte IE 9]><script type="text/javascript" src="/gzip_e7393341757851d76c3264b590cf5143/js/browserupdate.js" ></script>
      <![endif]-->
      <script src="../js/adsct" type="text/javascript"></script><script type="text/javascript" id="createCookie">(function(){var b="bestpractice.bmj.com\/topics\/en-gb\/116\/epidemiology",a=function(a,b,d){var e="",c=new Date;d&&(c.setTime(c.getTime()+864E5*d),e="; expires\x3d"+c.toGMTString());document.cookie=a+"\x3d"+b+e+"; path\x3d/; domain\x3dbmj.com"};a("RefTrack",b,2);a("RefTrackGroup","bestpractice.bmj.com",2)})();</script><script type="text/javascript" id="copyText">function getSelectionText(){var a="";window.getSelection?a=window.getSelection().toString():document.selection&&"Control"!=document.selection.type&&(a=document.selection.createRange().text);return a}document.addEventListener("copy",function(a){dataLayer.push({event:"textCopied",clipboardText:getSelectionText(),clipboardLength:getSelectionText().length})});</script>
      <script type="text/javascript" id="facebookPixel">!function(b,e,f,g,a,c,d){b.fbq||(a=b.fbq=function(){a.callMethod?a.callMethod.apply(a,arguments):a.queue.push(arguments)},b._fbq||(b._fbq=a),a.push=a,a.loaded=!0,a.version="2.0",a.queue=[],c=e.createElement(f),c.async=!0,c.src=g,d=e.getElementsByTagName(f)[0],d.parentNode.insertBefore(c,d))}(window,document,"script","https://connect.facebook.net/en_US/fbevents.js");fbq("init","414393182248444");fbq("track","PageView");</script>
      <noscript><img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=414393182248444&amp;ev=PageView&amp;noscript=1"></noscript>
      <script src="../js/saved_resource" type="text/javascript"></script>
   </body>
</html>